Literature DB >> 7964712

A comparison of clonidine, cyproheptadine and baclofen in spastic spinal cord injured patients.

P W Nance1.   

Abstract

In twenty-five SCI subjects, antispasticity effects of three putative antispasticity agents [clonidine (an alpha-2 noradrenergic agonist), cyproheptadine (a 5-HT2 antagonist) and baclofen (a GABA-B agonist)] were tested in terms of changes in leg tone as graded by the Ashworth scale (AS), in terms of the vibratory inhibition of the H-reflex (VII) and in terms of the ability of the knee to swing passively in the pendulum test as quantified by video motion analysis. When compared to the no drug period, all three drug treatments showed an antispasticity effect on the AS, the VII and the amplitude of the first swing and the relaxation index of the pendulum test, p. < 0001. Surprisingly, cyproheptadine and baclofen produced a greater reduction in the VII than clonidine, p. < 01. The amplitude of the first swing in the pendulum test correlated well with the AS, r = .88, and the antispasticity effects of the drugs produced improvements in both measures, a reduced AS and increased amplitude of knee swing in the pendulum test. Therefore, video motion analysis of the pendulum test is as valid a measure of spasticity as the Ashworth scale and is not limited by subjectivity of the examiner.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964712     DOI: 10.1080/01952307.1994.11735927

Source DB:  PubMed          Journal:  J Am Paraplegia Soc        ISSN: 0195-2307


  8 in total

1.  Adrenergic receptors modulate motoneuron excitability, sensory synaptic transmission and muscle spasms after chronic spinal cord injury.

Authors:  M M Rank; K C Murray; M J Stephens; J D'Amico; M A Gorassini; D J Bennett
Journal:  J Neurophysiol       Date:  2010-11-03       Impact factor: 2.714

2.  A Review of Spasticity Treatments: Pharmacological and Interventional Approaches.

Authors:  Eric Chang; Nilasha Ghosh; Daniel Yanni; Sujin Lee; Daniela Alexandru; Tahseen Mozaffar
Journal:  Crit Rev Phys Rehabil Med       Date:  2013

3.  Use of cyproheptadine hydrochloride (HCl) to reduce neuromuscular hypertonicity in stroke survivors: A Randomized Trial: Reducing Hypertonicity in Stroke.

Authors:  Derek Kamper; Alexander Barry; Naveen Bansal; Mary Ellen Stoykov; Kristen Triandafilou; Lynn Vidakovic; NaJin Seo; Elliot Roth
Journal:  J Stroke Cerebrovasc Dis       Date:  2022-08-30       Impact factor: 2.677

4.  Constitutively active 5-HT2/α1 receptors facilitate muscle spasms after human spinal cord injury.

Authors:  Jessica M D'Amico; Katherine C Murray; Yaqing Li; K Ming Chan; Mark G Finlay; David J Bennett; Monica A Gorassini
Journal:  J Neurophysiol       Date:  2012-12-05       Impact factor: 2.714

5.  Modulation of responses of feline gamma-motoneurones by noradrenaline, tizanidine and clonidine.

Authors:  E Jankowska; M H Gladden; J Czarkowska-Bauch
Journal:  J Physiol       Date:  1998-10-15       Impact factor: 5.182

Review 6.  Recovery of neuronal and network excitability after spinal cord injury and implications for spasticity.

Authors:  Jessica M D'Amico; Elizabeth G Condliffe; Karen J B Martins; David J Bennett; Monica A Gorassini
Journal:  Front Integr Neurosci       Date:  2014-05-12

7.  Early escitalopram administration as a preemptive treatment strategy against spasticity after contusive spinal cord injury in rats.

Authors:  Youngjae Ryu; Toru Ogata; Motoshi Nagao; Yasuhiro Sawada; Ryohei Nishimura; Naoki Fujita
Journal:  Sci Rep       Date:  2021-03-29       Impact factor: 4.379

8.  Pendulum test in chronic hemiplegic stroke population: additional ambulatory information beyond spasticity.

Authors:  Yin-Kai Dean Huang; Wei Li; Yi-Lin Chou; Erica Shih-Wei Hung; Jiunn-Horng Kang
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.